Exodus Point Capital Management, LP Nymox Pharmaceutical Corp Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.3 - $2.23 $95,915 - $164,531
-73,781 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.46 - $2.48 $107,720 - $182,976
73,781 New
73,781 $117,000
Q2 2020

Aug 14, 2020
SELL
$2.1 - $4.6 $118,897 - $260,442
-56,618 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.69 - $3.88 $70,146 - $161,047
-41,507 Reduced 42.3%
56,618 $132,000
Q4 2019

Feb 14, 2020
BUY
$1.73 - $2.42 $169,756 - $237,462
98,125 New
98,125 $216,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email